Quarterly ResultAug 6, 2026, 04:35 PM
LifeStance Q2 Revenue Up 26% to $435.4M; Swings to Profit
AI Summary
LifeStance Health Group reported strong second-quarter 2026 results, with total revenue increasing significantly by 26.08% to $435.4 million. The company successfully swung to a net income of $23.6 million, a substantial improvement from a net loss in the prior year. Additionally, LifeStance completed three acquisitions and repurchased $97.6 million in common stock during the first half of 2026, demonstrating strategic growth and capital management.
Key Highlights
- Q2 2026 revenue rose 26.08% to $435.4 million.
- Q2 2026 net income was $23.6 million, up from a $3.8 million net loss in Q2 2025.
- Basic and diluted EPS for Q2 2026 was $0.06, compared to $(0.01) in Q2 2025.
- H1 2026 net cash provided by operating activities increased 117% to $133.0 million.
- Acquired three mental health practices for $13.1 million in H1 2026.
- Repurchased $97.6 million of common stock during the first six months of 2026.
- Commercial payors accounted for 88% of total revenue in H1 2026.
Price Impact
More from LFST